ADC Therapeutics SA (NYSE:ADCT)

Delayed Data
As of Jun 06
 -0.01 / -0.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 10.00, with a high estimate of 17.00 and a low estimate of 2.00. The median estimate represents a +293.70% increase from the last price of 2.54.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.21%
Growthannually -30.73%


Growthquarterly 5.41%
Growthannually -54.31%
Key to the earnings and sales forecast charts.